nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SRD5A1—type 2 diabetes mellitus	0.348	0.571	CbGaD
Levonorgestrel—SHBG—type 2 diabetes mellitus	0.118	0.193	CbGaD
Levonorgestrel—AR—type 2 diabetes mellitus	0.103	0.169	CbGaD
Levonorgestrel—CYP3A4—type 2 diabetes mellitus	0.0406	0.0666	CbGaD
Levonorgestrel—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0229	0.152	CbGbCtD
Levonorgestrel—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0204	0.136	CbGbCtD
Levonorgestrel—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0187	0.124	CbGbCtD
Levonorgestrel—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0163	0.109	CbGbCtD
Levonorgestrel—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0147	0.0982	CbGbCtD
Levonorgestrel—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0112	0.0744	CbGbCtD
Levonorgestrel—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0107	0.0714	CbGbCtD
Levonorgestrel—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0107	0.0714	CbGbCtD
Levonorgestrel—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0101	0.0675	CbGbCtD
Levonorgestrel—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00755	0.0503	CbGbCtD
Levonorgestrel—CYP3A4—Losartan—type 2 diabetes mellitus	0.00691	0.046	CbGbCtD
Levonorgestrel—SHBG—hindlimb—type 2 diabetes mellitus	0.00246	0.187	CbGeAlD
Levonorgestrel—AR—penis—type 2 diabetes mellitus	0.00234	0.178	CbGeAlD
Levonorgestrel—PGR—artery—type 2 diabetes mellitus	0.00136	0.103	CbGeAlD
Levonorgestrel—SRD5A1—liver—type 2 diabetes mellitus	0.00089	0.0676	CbGeAlD
Levonorgestrel—SHBG—cardiovascular system—type 2 diabetes mellitus	0.000524	0.0398	CbGeAlD
Levonorgestrel—PGR—cardiovascular system—type 2 diabetes mellitus	0.000472	0.0359	CbGeAlD
Levonorgestrel—SHBG—adipose tissue—type 2 diabetes mellitus	0.000462	0.0351	CbGeAlD
Levonorgestrel—PGR—adipose tissue—type 2 diabetes mellitus	0.000416	0.0316	CbGeAlD
Levonorgestrel—AR—cardiovascular system—type 2 diabetes mellitus	0.000376	0.0286	CbGeAlD
Levonorgestrel—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000375	0.0285	CbGeAlD
Levonorgestrel—ESR1—cardiovascular system—type 2 diabetes mellitus	0.000369	0.028	CbGeAlD
Levonorgestrel—AR—kidney—type 2 diabetes mellitus	0.000368	0.028	CbGeAlD
Levonorgestrel—ESR1—kidney—type 2 diabetes mellitus	0.000361	0.0274	CbGeAlD
Levonorgestrel—AR—cortex of kidney—type 2 diabetes mellitus	0.000358	0.0272	CbGeAlD
Levonorgestrel—AR—adipose tissue—type 2 diabetes mellitus	0.000332	0.0252	CbGeAlD
Levonorgestrel—ESR1—adipose tissue—type 2 diabetes mellitus	0.000326	0.0247	CbGeAlD
Levonorgestrel—SHBG—liver—type 2 diabetes mellitus	0.000324	0.0246	CbGeAlD
Levonorgestrel—Desogestrel—SHBG—type 2 diabetes mellitus	0.000317	0.0771	CrCbGaD
Levonorgestrel—Nandrolone phenpropionate—AR—type 2 diabetes mellitus	0.000315	0.0768	CrCbGaD
Levonorgestrel—Danazol—CCL2—type 2 diabetes mellitus	0.00029	0.0706	CrCbGaD
Levonorgestrel—CYP19A1—liver—type 2 diabetes mellitus	0.000263	0.02	CbGeAlD
Levonorgestrel—Etonogestrel—SHBG—type 2 diabetes mellitus	0.000256	0.0624	CrCbGaD
Levonorgestrel—Nandrolone decanoate—AR—type 2 diabetes mellitus	0.000239	0.0582	CrCbGaD
Levonorgestrel—AR—liver—type 2 diabetes mellitus	0.000233	0.0177	CbGeAlD
Levonorgestrel—Norgestimate—ABCC2—type 2 diabetes mellitus	0.000231	0.0562	CrCbGaD
Levonorgestrel—ESR1—liver—type 2 diabetes mellitus	0.000228	0.0173	CbGeAlD
Levonorgestrel—CYP3A4—kidney—type 2 diabetes mellitus	0.000202	0.0153	CbGeAlD
Levonorgestrel—Danazol—SHBG—type 2 diabetes mellitus	0.000165	0.0402	CrCbGaD
Levonorgestrel—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000164	0.0398	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—SHBG—type 2 diabetes mellitus	0.000153	0.0372	CrCbGaD
Levonorgestrel—Norethindrone—SHBG—type 2 diabetes mellitus	0.000147	0.0358	CrCbGaD
Levonorgestrel—Danazol—AR—type 2 diabetes mellitus	0.000145	0.0353	CrCbGaD
Levonorgestrel—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.00014	0.034	CrCbGaD
Levonorgestrel—CYP3A4—liver—type 2 diabetes mellitus	0.000127	0.00968	CbGeAlD
Levonorgestrel—Methyltestosterone—AR—type 2 diabetes mellitus	0.000122	0.0298	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ABCC2—type 2 diabetes mellitus	0.000119	0.029	CrCbGaD
Levonorgestrel—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000115	0.028	CrCbGaD
Levonorgestrel—Allylestrenol—CYP3A4—type 2 diabetes mellitus	0.000113	0.0276	CrCbGaD
Levonorgestrel—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000105	0.0256	CrCbGaD
Levonorgestrel—Etonogestrel—CYP3A4—type 2 diabetes mellitus	8.84e-05	0.0215	CrCbGaD
Levonorgestrel—Progesterone—SHBG—type 2 diabetes mellitus	8.57e-05	0.0208	CrCbGaD
Levonorgestrel—Vertigo—Irbesartan—type 2 diabetes mellitus	8.34e-05	0.000563	CcSEcCtD
Levonorgestrel—Headache—Pioglitazone—type 2 diabetes mellitus	8.33e-05	0.000563	CcSEcCtD
Levonorgestrel—Syncope—Irbesartan—type 2 diabetes mellitus	8.32e-05	0.000562	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	8.31e-05	0.000562	CcSEcCtD
Levonorgestrel—Visual impairment—Ramipril—type 2 diabetes mellitus	8.29e-05	0.00056	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	8.28e-05	0.000559	CcSEcCtD
Levonorgestrel—Discomfort—Metformin—type 2 diabetes mellitus	8.27e-05	0.000559	CcSEcCtD
Levonorgestrel—Fatigue—Gliclazide—type 2 diabetes mellitus	8.27e-05	0.000559	CcSEcCtD
Levonorgestrel—Nausea—Glipizide—type 2 diabetes mellitus	8.24e-05	0.000557	CcSEcCtD
Levonorgestrel—Vomiting—Glimepiride—type 2 diabetes mellitus	8.24e-05	0.000556	CcSEcCtD
Levonorgestrel—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.21e-05	0.000555	CcSEcCtD
Levonorgestrel—Constipation—Gliclazide—type 2 diabetes mellitus	8.2e-05	0.000554	CcSEcCtD
Levonorgestrel—Pain—Gliclazide—type 2 diabetes mellitus	8.2e-05	0.000554	CcSEcCtD
Levonorgestrel—Rash—Glimepiride—type 2 diabetes mellitus	8.17e-05	0.000552	CcSEcCtD
Levonorgestrel—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.16e-05	0.000551	CcSEcCtD
Levonorgestrel—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000551	CcSEcCtD
Levonorgestrel—Rash—Sitagliptin—type 2 diabetes mellitus	8.14e-05	0.00055	CcSEcCtD
Levonorgestrel—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.13e-05	0.000549	CcSEcCtD
Levonorgestrel—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000549	CcSEcCtD
Levonorgestrel—Headache—Glimepiride—type 2 diabetes mellitus	8.11e-05	0.000548	CcSEcCtD
Levonorgestrel—Cough—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000547	CcSEcCtD
Levonorgestrel—Testosterone—SHBG—type 2 diabetes mellitus	8.1e-05	0.0197	CrCbGaD
Levonorgestrel—Headache—Sitagliptin—type 2 diabetes mellitus	8.09e-05	0.000546	CcSEcCtD
Levonorgestrel—Anaemia—Losartan—type 2 diabetes mellitus	8.07e-05	0.000545	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.03e-05	0.000542	CcSEcCtD
Levonorgestrel—Oedema—Metformin—type 2 diabetes mellitus	8.03e-05	0.000542	CcSEcCtD
Levonorgestrel—Hypertension—Irbesartan—type 2 diabetes mellitus	8.01e-05	0.000541	CcSEcCtD
Levonorgestrel—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8e-05	0.00054	CcSEcCtD
Levonorgestrel—Angioedema—Losartan—type 2 diabetes mellitus	7.98e-05	0.000539	CcSEcCtD
Levonorgestrel—Infection—Metformin—type 2 diabetes mellitus	7.97e-05	0.000539	CcSEcCtD
Levonorgestrel—Insomnia—Valsartan—type 2 diabetes mellitus	7.97e-05	0.000538	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.93e-05	0.000536	CcSEcCtD
Levonorgestrel—Myalgia—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000534	CcSEcCtD
Levonorgestrel—Chest pain—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000534	CcSEcCtD
Levonorgestrel—Shock—Metformin—type 2 diabetes mellitus	7.9e-05	0.000533	CcSEcCtD
Levonorgestrel—Insomnia—Orlistat—type 2 diabetes mellitus	7.88e-05	0.000532	CcSEcCtD
Levonorgestrel—Anxiety—Irbesartan—type 2 diabetes mellitus	7.87e-05	0.000532	CcSEcCtD
Levonorgestrel—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.87e-05	0.000532	CcSEcCtD
Levonorgestrel—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.87e-05	0.000532	CcSEcCtD
Levonorgestrel—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.86e-05	0.000531	CcSEcCtD
Levonorgestrel—Vertigo—Losartan—type 2 diabetes mellitus	7.85e-05	0.00053	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.00053	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.00053	CcSEcCtD
Levonorgestrel—Somnolence—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000529	CcSEcCtD
Levonorgestrel—Syncope—Losartan—type 2 diabetes mellitus	7.83e-05	0.000529	CcSEcCtD
Levonorgestrel—Discomfort—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000527	CcSEcCtD
Levonorgestrel—Skin disorder—Metformin—type 2 diabetes mellitus	7.8e-05	0.000527	CcSEcCtD
Levonorgestrel—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000525	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.76e-05	0.000524	CcSEcCtD
Levonorgestrel—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.76e-05	0.000524	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000524	CcSEcCtD
Levonorgestrel—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.73e-05	0.000522	CcSEcCtD
Levonorgestrel—Palpitations—Losartan—type 2 diabetes mellitus	7.72e-05	0.000521	CcSEcCtD
Levonorgestrel—Nausea—Glimepiride—type 2 diabetes mellitus	7.69e-05	0.00052	CcSEcCtD
Levonorgestrel—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000519	CcSEcCtD
Levonorgestrel—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.68e-05	0.000518	CcSEcCtD
Levonorgestrel—Nausea—Sitagliptin—type 2 diabetes mellitus	7.67e-05	0.000518	CcSEcCtD
Levonorgestrel—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.67e-05	0.000518	CcSEcCtD
Levonorgestrel—Asthenia—Glyburide—type 2 diabetes mellitus	7.66e-05	0.000518	CcSEcCtD
Levonorgestrel—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.66e-05	0.000517	CcSEcCtD
Levonorgestrel—Anorexia—Metformin—type 2 diabetes mellitus	7.65e-05	0.000517	CcSEcCtD
Levonorgestrel—Cough—Losartan—type 2 diabetes mellitus	7.62e-05	0.000515	CcSEcCtD
Levonorgestrel—Urticaria—Gliclazide—type 2 diabetes mellitus	7.62e-05	0.000515	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.61e-05	0.000514	CcSEcCtD
Levonorgestrel—Alopecia—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000513	CcSEcCtD
Levonorgestrel—Fatigue—Valsartan—type 2 diabetes mellitus	7.6e-05	0.000513	CcSEcCtD
Levonorgestrel—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.58e-05	0.000512	CcSEcCtD
Levonorgestrel—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.58e-05	0.000512	CcSEcCtD
Levonorgestrel—Oedema—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000512	CcSEcCtD
Levonorgestrel—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.57e-05	0.000511	CcSEcCtD
Levonorgestrel—Pruritus—Glyburide—type 2 diabetes mellitus	7.56e-05	0.000511	CcSEcCtD
Levonorgestrel—Mental disorder—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000509	CcSEcCtD
Levonorgestrel—Constipation—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000509	CcSEcCtD
Levonorgestrel—Infection—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000508	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.52e-05	0.000508	CcSEcCtD
Levonorgestrel—Progesterone—AR—type 2 diabetes mellitus	7.51e-05	0.0183	CrCbGaD
Levonorgestrel—Fatigue—Orlistat—type 2 diabetes mellitus	7.51e-05	0.000507	CcSEcCtD
Levonorgestrel—Malnutrition—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000506	CcSEcCtD
Levonorgestrel—Erythema—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000506	CcSEcCtD
Levonorgestrel—Shock—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000503	CcSEcCtD
Levonorgestrel—Pain—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000503	CcSEcCtD
Levonorgestrel—Chest pain—Losartan—type 2 diabetes mellitus	7.44e-05	0.000502	CcSEcCtD
Levonorgestrel—Myalgia—Losartan—type 2 diabetes mellitus	7.44e-05	0.000502	CcSEcCtD
Levonorgestrel—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.43e-05	0.000502	CcSEcCtD
Levonorgestrel—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.43e-05	0.000502	CcSEcCtD
Levonorgestrel—Anxiety—Losartan—type 2 diabetes mellitus	7.41e-05	0.0005	CcSEcCtD
Levonorgestrel—Rash—Bromocriptine—type 2 diabetes mellitus	7.37e-05	0.000498	CcSEcCtD
Levonorgestrel—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.36e-05	0.000497	CcSEcCtD
Levonorgestrel—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000497	CcSEcCtD
Levonorgestrel—Tension—Ramipril—type 2 diabetes mellitus	7.35e-05	0.000496	CcSEcCtD
Levonorgestrel—Discomfort—Losartan—type 2 diabetes mellitus	7.35e-05	0.000496	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000495	CcSEcCtD
Levonorgestrel—Headache—Bromocriptine—type 2 diabetes mellitus	7.32e-05	0.000494	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.31e-05	0.000494	CcSEcCtD
Levonorgestrel—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.31e-05	0.000494	CcSEcCtD
Levonorgestrel—Nervousness—Ramipril—type 2 diabetes mellitus	7.27e-05	0.000491	CcSEcCtD
Levonorgestrel—Anorexia—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000488	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.21e-05	0.000487	CcSEcCtD
Levonorgestrel—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000486	CcSEcCtD
Levonorgestrel—Dyspnoea—Metformin—type 2 diabetes mellitus	7.16e-05	0.000483	CcSEcCtD
Levonorgestrel—Somnolence—Metformin—type 2 diabetes mellitus	7.13e-05	0.000482	CcSEcCtD
Levonorgestrel—Oedema—Losartan—type 2 diabetes mellitus	7.13e-05	0.000481	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.12e-05	0.000481	CcSEcCtD
Levonorgestrel—Testosterone—AR—type 2 diabetes mellitus	7.1e-05	0.0173	CrCbGaD
Levonorgestrel—Infection—Losartan—type 2 diabetes mellitus	7.08e-05	0.000478	CcSEcCtD
Levonorgestrel—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.07e-05	0.000477	CcSEcCtD
Levonorgestrel—Dyspepsia—Metformin—type 2 diabetes mellitus	7.06e-05	0.000477	CcSEcCtD
Levonorgestrel—Shock—Losartan—type 2 diabetes mellitus	7.01e-05	0.000474	CcSEcCtD
Levonorgestrel—Urticaria—Valsartan—type 2 diabetes mellitus	7e-05	0.000473	CcSEcCtD
Levonorgestrel—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.99e-05	0.000472	CcSEcCtD
Levonorgestrel—Decreased appetite—Metformin—type 2 diabetes mellitus	6.98e-05	0.000471	CcSEcCtD
Levonorgestrel—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.97e-05	0.000471	CcSEcCtD
Levonorgestrel—Nausea—Bromocriptine—type 2 diabetes mellitus	6.94e-05	0.000469	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.93e-05	0.000468	CcSEcCtD
Levonorgestrel—Fatigue—Metformin—type 2 diabetes mellitus	6.92e-05	0.000467	CcSEcCtD
Levonorgestrel—Urticaria—Orlistat—type 2 diabetes mellitus	6.92e-05	0.000467	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000466	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.89e-05	0.000465	CcSEcCtD
Levonorgestrel—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000465	CcSEcCtD
Levonorgestrel—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000465	CcSEcCtD
Levonorgestrel—Asthenia—Gliclazide—type 2 diabetes mellitus	6.88e-05	0.000465	CcSEcCtD
Levonorgestrel—Constipation—Metformin—type 2 diabetes mellitus	6.86e-05	0.000464	CcSEcCtD
Levonorgestrel—Angioedema—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000462	CcSEcCtD
Levonorgestrel—Anorexia—Losartan—type 2 diabetes mellitus	6.79e-05	0.000459	CcSEcCtD
Levonorgestrel—Vomiting—Glyburide—type 2 diabetes mellitus	6.79e-05	0.000459	CcSEcCtD
Levonorgestrel—Pruritus—Gliclazide—type 2 diabetes mellitus	6.79e-05	0.000458	CcSEcCtD
Levonorgestrel—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000456	CcSEcCtD
Levonorgestrel—Rash—Glyburide—type 2 diabetes mellitus	6.74e-05	0.000455	CcSEcCtD
Levonorgestrel—Somnolence—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000455	CcSEcCtD
Levonorgestrel—Dermatitis—Glyburide—type 2 diabetes mellitus	6.73e-05	0.000455	CcSEcCtD
Levonorgestrel—Vertigo—Ramipril—type 2 diabetes mellitus	6.73e-05	0.000454	CcSEcCtD
Levonorgestrel—Syncope—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000454	CcSEcCtD
Levonorgestrel—Headache—Glyburide—type 2 diabetes mellitus	6.69e-05	0.000452	CcSEcCtD
Levonorgestrel—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.00045	CcSEcCtD
Levonorgestrel—Palpitations—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000447	CcSEcCtD
Levonorgestrel—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000445	CcSEcCtD
Levonorgestrel—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000445	CcSEcCtD
Levonorgestrel—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000443	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.56e-05	0.000443	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000442	CcSEcCtD
Levonorgestrel—Cough—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000441	CcSEcCtD
Levonorgestrel—Fatigue—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000441	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.49e-05	0.000439	CcSEcCtD
Levonorgestrel—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.49e-05	0.000439	CcSEcCtD
Levonorgestrel—Constipation—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000437	CcSEcCtD
Levonorgestrel—Pain—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000437	CcSEcCtD
Levonorgestrel—Insomnia—Losartan—type 2 diabetes mellitus	6.45e-05	0.000435	CcSEcCtD
Levonorgestrel—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.42e-05	0.000433	CcSEcCtD
Levonorgestrel—Urticaria—Metformin—type 2 diabetes mellitus	6.38e-05	0.000431	CcSEcCtD
Levonorgestrel—Myalgia—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000431	CcSEcCtD
Levonorgestrel—Chest pain—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000431	CcSEcCtD
Levonorgestrel—Dyspnoea—Losartan—type 2 diabetes mellitus	6.35e-05	0.000429	CcSEcCtD
Levonorgestrel—Anxiety—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000429	CcSEcCtD
Levonorgestrel—Nausea—Glyburide—type 2 diabetes mellitus	6.35e-05	0.000429	CcSEcCtD
Levonorgestrel—Abdominal pain—Metformin—type 2 diabetes mellitus	6.34e-05	0.000429	CcSEcCtD
Levonorgestrel—Dizziness—Gliclazide—type 2 diabetes mellitus	6.34e-05	0.000428	CcSEcCtD
Levonorgestrel—Somnolence—Losartan—type 2 diabetes mellitus	6.34e-05	0.000428	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000428	CcSEcCtD
Levonorgestrel—Asthenia—Valsartan—type 2 diabetes mellitus	6.32e-05	0.000427	CcSEcCtD
Levonorgestrel—Discomfort—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000425	CcSEcCtD
Levonorgestrel—Dyspepsia—Losartan—type 2 diabetes mellitus	6.27e-05	0.000424	CcSEcCtD
Levonorgestrel—Hydrocortisone—NR3C1—type 2 diabetes mellitus	6.25e-05	0.0152	CrCbGaD
Levonorgestrel—Asthenia—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000422	CcSEcCtD
Levonorgestrel—Pruritus—Valsartan—type 2 diabetes mellitus	6.24e-05	0.000421	CcSEcCtD
Levonorgestrel—Decreased appetite—Losartan—type 2 diabetes mellitus	6.2e-05	0.000419	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000418	CcSEcCtD
Levonorgestrel—Pruritus—Orlistat—type 2 diabetes mellitus	6.16e-05	0.000416	CcSEcCtD
Levonorgestrel—Fatigue—Losartan—type 2 diabetes mellitus	6.15e-05	0.000415	CcSEcCtD
Levonorgestrel—Oedema—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000413	CcSEcCtD
Levonorgestrel—Vomiting—Gliclazide—type 2 diabetes mellitus	6.1e-05	0.000412	CcSEcCtD
Levonorgestrel—Pain—Losartan—type 2 diabetes mellitus	6.1e-05	0.000412	CcSEcCtD
Levonorgestrel—Constipation—Losartan—type 2 diabetes mellitus	6.1e-05	0.000412	CcSEcCtD
Levonorgestrel—Rash—Gliclazide—type 2 diabetes mellitus	6.05e-05	0.000409	CcSEcCtD
Levonorgestrel—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.04e-05	0.000408	CcSEcCtD
Levonorgestrel—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.03e-05	0.000407	CcSEcCtD
Levonorgestrel—Urticaria—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000406	CcSEcCtD
Levonorgestrel—Shock—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000406	CcSEcCtD
Levonorgestrel—Headache—Gliclazide—type 2 diabetes mellitus	6.01e-05	0.000406	CcSEcCtD
Levonorgestrel—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000405	CcSEcCtD
Levonorgestrel—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000404	CcSEcCtD
Levonorgestrel—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000404	CcSEcCtD
Levonorgestrel—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.96e-05	0.000402	CcSEcCtD
Levonorgestrel—Skin disorder—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000401	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000399	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.83e-05	0.000394	CcSEcCtD
Levonorgestrel—Dizziness—Valsartan—type 2 diabetes mellitus	5.83e-05	0.000394	CcSEcCtD
Levonorgestrel—Anorexia—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000394	CcSEcCtD
Levonorgestrel—Dizziness—Orlistat—type 2 diabetes mellitus	5.76e-05	0.000389	CcSEcCtD
Levonorgestrel—Asthenia—Metformin—type 2 diabetes mellitus	5.76e-05	0.000389	CcSEcCtD
Levonorgestrel—Nausea—Gliclazide—type 2 diabetes mellitus	5.7e-05	0.000385	CcSEcCtD
Levonorgestrel—Danazol—CYP3A4—type 2 diabetes mellitus	5.69e-05	0.0139	CrCbGaD
Levonorgestrel—Pruritus—Metformin—type 2 diabetes mellitus	5.68e-05	0.000384	CcSEcCtD
Levonorgestrel—Urticaria—Losartan—type 2 diabetes mellitus	5.66e-05	0.000382	CcSEcCtD
Levonorgestrel—Body temperature increased—Losartan—type 2 diabetes mellitus	5.63e-05	0.000381	CcSEcCtD
Levonorgestrel—Abdominal pain—Losartan—type 2 diabetes mellitus	5.63e-05	0.000381	CcSEcCtD
Levonorgestrel—Vomiting—Valsartan—type 2 diabetes mellitus	5.6e-05	0.000379	CcSEcCtD
Levonorgestrel—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000377	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000376	CcSEcCtD
Levonorgestrel—Rash—Valsartan—type 2 diabetes mellitus	5.56e-05	0.000375	CcSEcCtD
Levonorgestrel—Dermatitis—Valsartan—type 2 diabetes mellitus	5.55e-05	0.000375	CcSEcCtD
Levonorgestrel—Vomiting—Orlistat—type 2 diabetes mellitus	5.54e-05	0.000374	CcSEcCtD
Levonorgestrel—Insomnia—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000373	CcSEcCtD
Levonorgestrel—Headache—Valsartan—type 2 diabetes mellitus	5.52e-05	0.000373	CcSEcCtD
Levonorgestrel—Diarrhoea—Metformin—type 2 diabetes mellitus	5.49e-05	0.000371	CcSEcCtD
Levonorgestrel—Rash—Orlistat—type 2 diabetes mellitus	5.49e-05	0.000371	CcSEcCtD
Levonorgestrel—Dermatitis—Orlistat—type 2 diabetes mellitus	5.49e-05	0.000371	CcSEcCtD
Levonorgestrel—Headache—Orlistat—type 2 diabetes mellitus	5.46e-05	0.000369	CcSEcCtD
Levonorgestrel—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000368	CcSEcCtD
Levonorgestrel—Asthenia—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000367	CcSEcCtD
Levonorgestrel—Somnolence—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000367	CcSEcCtD
Levonorgestrel—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000363	CcSEcCtD
Levonorgestrel—Pruritus—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000362	CcSEcCtD
Levonorgestrel—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000359	CcSEcCtD
Levonorgestrel—Dizziness—Metformin—type 2 diabetes mellitus	5.31e-05	0.000358	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000356	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—CYP3A4—type 2 diabetes mellitus	5.27e-05	0.0128	CrCbGaD
Levonorgestrel—Fatigue—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000356	CcSEcCtD
Levonorgestrel—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.25e-05	0.000355	CcSEcCtD
Levonorgestrel—Nausea—Valsartan—type 2 diabetes mellitus	5.23e-05	0.000354	CcSEcCtD
Levonorgestrel—Constipation—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000353	CcSEcCtD
Levonorgestrel—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.00035	CcSEcCtD
Levonorgestrel—Nausea—Orlistat—type 2 diabetes mellitus	5.17e-05	0.000349	CcSEcCtD
Levonorgestrel—Asthenia—Losartan—type 2 diabetes mellitus	5.11e-05	0.000345	CcSEcCtD
Levonorgestrel—Vomiting—Metformin—type 2 diabetes mellitus	5.1e-05	0.000345	CcSEcCtD
Levonorgestrel—Progesterone—NR3C1—type 2 diabetes mellitus	5.09e-05	0.0124	CrCbGaD
Levonorgestrel—Norethindrone—CYP3A4—type 2 diabetes mellitus	5.07e-05	0.0123	CrCbGaD
Levonorgestrel—Rash—Metformin—type 2 diabetes mellitus	5.06e-05	0.000342	CcSEcCtD
Levonorgestrel—Dermatitis—Metformin—type 2 diabetes mellitus	5.06e-05	0.000341	CcSEcCtD
Levonorgestrel—Pruritus—Losartan—type 2 diabetes mellitus	5.04e-05	0.000341	CcSEcCtD
Levonorgestrel—Headache—Metformin—type 2 diabetes mellitus	5.03e-05	0.00034	CcSEcCtD
Levonorgestrel—Dizziness—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000338	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5e-05	0.000338	CcSEcCtD
Levonorgestrel—Diarrhoea—Losartan—type 2 diabetes mellitus	4.88e-05	0.000329	CcSEcCtD
Levonorgestrel—Urticaria—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000328	CcSEcCtD
Levonorgestrel—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000326	CcSEcCtD
Levonorgestrel—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000326	CcSEcCtD
Levonorgestrel—Vomiting—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000325	CcSEcCtD
Levonorgestrel—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	4.81e-05	0.0117	CrCbGaD
Levonorgestrel—Rash—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000323	CcSEcCtD
Levonorgestrel—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000322	CcSEcCtD
Levonorgestrel—Nausea—Metformin—type 2 diabetes mellitus	4.77e-05	0.000322	CcSEcCtD
Levonorgestrel—Headache—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.00032	CcSEcCtD
Levonorgestrel—Dizziness—Losartan—type 2 diabetes mellitus	4.71e-05	0.000318	CcSEcCtD
Levonorgestrel—Vomiting—Losartan—type 2 diabetes mellitus	4.53e-05	0.000306	CcSEcCtD
Levonorgestrel—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Levonorgestrel—Nausea—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000304	CcSEcCtD
Levonorgestrel—Rash—Losartan—type 2 diabetes mellitus	4.49e-05	0.000304	CcSEcCtD
Levonorgestrel—Dermatitis—Losartan—type 2 diabetes mellitus	4.49e-05	0.000303	CcSEcCtD
Levonorgestrel—Headache—Losartan—type 2 diabetes mellitus	4.47e-05	0.000302	CcSEcCtD
Levonorgestrel—Progesterone—CYP1A2—type 2 diabetes mellitus	4.46e-05	0.0109	CrCbGaD
Levonorgestrel—Norethindrone—ALB—type 2 diabetes mellitus	4.42e-05	0.0108	CrCbGaD
Levonorgestrel—Asthenia—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000296	CcSEcCtD
Levonorgestrel—Pruritus—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000292	CcSEcCtD
Levonorgestrel—Nausea—Losartan—type 2 diabetes mellitus	4.23e-05	0.000286	CcSEcCtD
Levonorgestrel—Methyltestosterone—ALB—type 2 diabetes mellitus	4.2e-05	0.0102	CrCbGaD
Levonorgestrel—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000282	CcSEcCtD
Levonorgestrel—Dizziness—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000273	CcSEcCtD
Levonorgestrel—Vomiting—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000262	CcSEcCtD
Levonorgestrel—Rash—Ramipril—type 2 diabetes mellitus	3.85e-05	0.00026	CcSEcCtD
Levonorgestrel—Dermatitis—Ramipril—type 2 diabetes mellitus	3.85e-05	0.00026	CcSEcCtD
Levonorgestrel—Headache—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000259	CcSEcCtD
Levonorgestrel—Nausea—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000245	CcSEcCtD
Levonorgestrel—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	3.62e-05	0.00882	CrCbGaD
Levonorgestrel—Progesterone—CYP3A4—type 2 diabetes mellitus	2.95e-05	0.00719	CrCbGaD
Levonorgestrel—Testosterone—CYP3A4—type 2 diabetes mellitus	2.79e-05	0.00679	CrCbGaD
Levonorgestrel—Testosterone—ALB—type 2 diabetes mellitus	2.43e-05	0.00593	CrCbGaD
Levonorgestrel—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	1.26e-05	0.000168	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	1.25e-05	0.000167	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	1.25e-05	0.000166	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.23e-05	0.000163	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.17e-05	0.000156	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.17e-05	0.000155	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.17e-05	0.000155	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.17e-05	0.000155	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	1.14e-05	0.000152	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.14e-05	0.000152	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—type 2 diabetes mellitus	1.14e-05	0.000151	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.13e-05	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.13e-05	0.000151	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.12e-05	0.000149	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.12e-05	0.000149	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.12e-05	0.000149	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.12e-05	0.000149	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	1.12e-05	0.000149	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.11e-05	0.000148	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.11e-05	0.000148	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.11e-05	0.000148	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.1e-05	0.000147	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.1e-05	0.000146	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AVP—type 2 diabetes mellitus	1.1e-05	0.000146	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.09e-05	0.000145	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.09e-05	0.000145	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.09e-05	0.000145	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.09e-05	0.000145	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.07e-05	0.000143	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AR—type 2 diabetes mellitus	1.06e-05	0.000142	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOB—type 2 diabetes mellitus	1.06e-05	0.000141	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.06e-05	0.000141	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-05	0.00014	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.05e-05	0.00014	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.05e-05	0.00014	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.05e-05	0.00014	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARA—type 2 diabetes mellitus	1.05e-05	0.000139	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.04e-05	0.000139	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.03e-05	0.000137	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.02e-05	0.000136	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.02e-05	0.000136	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LPL—type 2 diabetes mellitus	1.01e-05	0.000135	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.01e-05	0.000135	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	1.01e-05	0.000135	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.91e-06	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	9.81e-06	0.000131	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	9.73e-06	0.00013	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	9.71e-06	0.000129	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	9.67e-06	0.000129	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	9.61e-06	0.000128	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.5e-06	0.000126	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	9.45e-06	0.000126	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	9.39e-06	0.000125	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.32e-06	0.000124	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	9.2e-06	0.000122	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	9.2e-06	0.000122	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—C3—type 2 diabetes mellitus	9.11e-06	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.99e-06	0.00012	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.73e-06	0.000116	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.73e-06	0.000116	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	8.72e-06	0.000116	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	8.72e-06	0.000116	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.72e-06	0.000116	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	8.72e-06	0.000116	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.69e-06	0.000116	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	8.68e-06	0.000115	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.67e-06	0.000115	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—type 2 diabetes mellitus	8.66e-06	0.000115	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGT—type 2 diabetes mellitus	8.66e-06	0.000115	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	8.61e-06	0.000115	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	8.57e-06	0.000114	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	8.56e-06	0.000114	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.51e-06	0.000113	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.49e-06	0.000113	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—type 2 diabetes mellitus	8.48e-06	0.000113	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—type 2 diabetes mellitus	8.48e-06	0.000113	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.46e-06	0.000113	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.39e-06	0.000112	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.32e-06	0.000111	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.31e-06	0.000111	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	8.31e-06	0.000111	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.28e-06	0.00011	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.28e-06	0.00011	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.18e-06	0.000109	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	8.08e-06	0.000108	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	8.07e-06	0.000107	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8e-06	0.000107	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	7.93e-06	0.000106	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	7.8e-06	0.000104	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	7.77e-06	0.000103	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	7.74e-06	0.000103	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.7e-06	0.000103	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.67e-06	0.000102	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.67e-06	0.000102	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.57e-06	0.000101	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	7.57e-06	0.000101	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.57e-06	0.000101	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	7.54e-06	0.0001	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.45e-06	9.91e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.44e-06	9.91e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.42e-06	9.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.41e-06	9.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.41e-06	9.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.41e-06	9.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.41e-06	9.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.41e-06	9.87e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	7.25e-06	9.65e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.18e-06	9.56e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	7.14e-06	9.51e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.13e-06	9.49e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.01e-06	9.33e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	7.01e-06	9.33e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	7e-06	9.33e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	6.79e-06	9.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.78e-06	9.03e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.78e-06	9.03e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	6.67e-06	8.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	6.67e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.66e-06	8.86e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	6.65e-06	8.85e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.61e-06	8.8e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.59e-06	8.77e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	6.57e-06	8.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.52e-06	8.69e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.44e-06	8.57e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.44e-06	8.57e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.41e-06	8.53e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.38e-06	8.49e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.36e-06	8.46e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.36e-06	8.46e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.3e-06	8.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.3e-06	8.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.3e-06	8.39e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.22e-06	8.28e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.2e-06	8.25e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.12e-06	8.15e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.04e-06	8.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.04e-06	8.04e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	6.01e-06	8e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	5.98e-06	7.96e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.94e-06	7.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.82e-06	7.74e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.82e-06	7.74e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.82e-06	7.74e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	5.79e-06	7.71e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.71e-06	7.61e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	5.68e-06	7.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.62e-06	7.48e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.62e-06	7.48e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.62e-06	7.48e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.57e-06	7.42e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.47e-06	7.29e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.4e-06	7.18e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	5.35e-06	7.12e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.28e-06	7.03e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	5.21e-06	6.93e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.1e-06	6.79e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.1e-06	6.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.09e-06	6.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.08e-06	6.76e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.04e-06	6.72e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5e-06	6.65e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	4.98e-06	6.63e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.98e-06	6.63e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.98e-06	6.63e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.98e-06	6.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.95e-06	6.58e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.92e-06	6.55e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.78e-06	6.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.78e-06	6.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.78e-06	6.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.78e-06	6.36e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	4.7e-06	6.26e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.7e-06	6.25e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.58e-06	6.1e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.58e-06	6.1e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	4.56e-06	6.07e-05	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	4.49e-06	5.98e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.44e-06	5.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.26e-06	5.67e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	4.25e-06	5.66e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.2e-06	5.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.18e-06	5.57e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.12e-06	5.49e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.11e-06	5.48e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.11e-06	5.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.97e-06	5.29e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.91e-06	5.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.89e-06	5.18e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.89e-06	5.18e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.82e-06	5.08e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.79e-06	5.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.79e-06	5.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.79e-06	5.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.77e-06	5.02e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.73e-06	4.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.73e-06	4.97e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.7e-06	4.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.66e-06	4.87e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.51e-06	4.67e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—type 2 diabetes mellitus	3.42e-06	4.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.4e-06	4.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.4e-06	4.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.4e-06	4.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.34e-06	4.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.31e-06	4.41e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.24e-06	4.31e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.17e-06	4.22e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	3.17e-06	4.22e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.11e-06	4.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.08e-06	4.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.08e-06	4.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.99e-06	3.98e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.96e-06	3.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.95e-06	3.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.95e-06	3.93e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.92e-06	3.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.76e-06	3.67e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.69e-06	3.58e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	2.64e-06	3.51e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.54e-06	3.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.54e-06	3.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.53e-06	3.37e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.5e-06	3.33e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.47e-06	3.28e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.43e-06	3.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.42e-06	3.22e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.36e-06	3.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.32e-06	3.08e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	2.29e-06	3.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.27e-06	3.02e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.26e-06	3.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.2e-06	2.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.17e-06	2.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.08e-06	2.78e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.05e-06	2.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.98e-06	2.64e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.95e-06	2.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.94e-06	2.58e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.92e-06	2.55e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.86e-06	2.47e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.71e-06	2.28e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	2.25e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.66e-06	2.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	2.02e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.77e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.68e-07	8.9e-06	CbGpPWpGaD
